Learn more

NANJING RONGJIEKANG BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    13
  • GoodIP Patent Rank
    128,332
About

NANJING RONGJIEKANG BIOTECHNOLOGY CO LTD has a total of 13 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ADURO BIOTECH HOLDINGS EUROPE B V, SCRIPPS KOREA ANTIBODY INST and MUELLER-HERMELINK HANS KONRAD.

Patent filings in countries

World map showing NANJING RONGJIEKANG BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 13

Patent filings per year

Chart showing NANJING RONGJIEKANG BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Su Zhipeng 11
#2 Meng Jinguo 4
#3 Xie Wei 3
#4 Yao Yao 3
#5 Zhou Geng 3
#6 Zhang Yun 3
#7 Wang Lefei 2
#8 Wang Yang 2
#9 Yu Xiaoxiao 2
#10 Han Ding 2

Latest patents

Publication Filing date Title
CN111690066A anti-IL-4R alpha single-domain antibody and application and medicament thereof
CN111333730A Single-domain antibody capable of specifically binding to EpCAM and application thereof
CN111040035A Antibody for IL-17RA protein and preparation method and application thereof
CN111138533A Single domain antibody against hepatitis A virus and derived protein thereof
CN111138532A Use of single domain antibodies against hepatitis a virus
CN111057154A Preparation and application of immunogen based on camel-derived Fc fragment
CN111057148A Single-domain antibody aiming at bovine serum albumin BSA and derivative protein thereof
CN111018985A Application of single-domain antibody aiming at bovine serum albumin BSA
CN110201158A Pharmaceutical composition
CN110204619A Chimeric antigen receptor and its application comprising Fc γ R I
CN109734808A Nano antibody and its application for the region HDAC6-cat1
CN109734804A Nano antibody and its application for H3K64Ac/H3K64 segment
CN109438577A Specificity is directed to the single domain antibody and its derived protein of V5 label protein